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Abstract Deleterious microcirculatory eﬀects of Intrali-
pid (IL) infusion may be caused by hemorheological or
vascular eﬀects. The aim of this investigation was to
study vascular and hemorheological eﬀects of IL in
preterm and fullterm neonates and children. Ten pre-
term newborns, 10 fullterm neonates, and 10 children
received an initial infusion of IL (0.6 g/kg) over 4 h. Calf
blood ﬂow (venous occlusion plethysmography), blood
pressure (Dinamap), whole blood and plasma viscosity
(capillary viscometer), red blood cell deformability
(rheoscope), and erythrocyte aggregation (aggregome-
ter) were measured before and after administration of
IL. Plasma triglyceride levels showed the greatest in-
crease in preterm infants. Whole blood viscosity de-
creased by about 10% in all three groups because of a
similar reduction in hematocrit. Red blood cell aggre-
gation decreased by about 20% after IL infusion. Blood
pressure rose by 10%, and peripheral blood ﬂow de-
clined by about 10% in the three groups. Vascular hin-
drance, a calculation of blood pressure divided by blood
ﬂow and viscosity, was raised by about 20%, suggesting
marked vasoconstriction of peripheral arteries. Vaso-
constriction rather than hemorheological changes dur-
ing infusion of IL may play a crucial role in the
pathogenesis of circulatory alterations in parenterally-
fed neonates.
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Introduction
Intravenous lipid emulsions of soybean triglycerides,
such as Intralipid (IL), are principally given to prevent
deﬁciency of essential fatty acids, to supply the necessary
calories for energy expenditure and growth, and to im-
prove the support of fat-soluble vitamins in patients of
all ages, including newborn infants.
Besides various metabolic side eﬀects of fat emulsions
in neonates, several papers report pulmonary compli-
cations in preterm infants as a result of IL infusion,
including fat embolism [1, 2], increased pulmonary vas-
cular resistance [3, 4], increased alveolar–arteriolar
oxygen gradient [5], and increased risk of bronchopul-
monary dysplasia [6, 7]. These observations have been
connected with lipid accretion in pulmonary microves-
sels [2] and with several mechanisms that inﬂuence
microcirculation, such as lipid peroxide production [8],
increased production of prostaglandins and thrombox-
ane [9, 10], and diminished bioavailability of the endo-
thelium-derived vascular relaxant NO [11]. Thus, a
relationship between IL infusion and microcirculatory
deterioration in neonates seems probable, although
clinical impact and mechanisms remain unclear.
In healthy adults, IL infusion has resulted in a marked
rise in systolic arterial blood pressure [12] and peripheral
[12] and systemic [13] vascular resistance. It has been
suggested that alterations of hemorheological properties
through hypertriglyceridemia caused by IL may be a
causative factor in the rise of peripheral resistance.
An increase in either vascular reactivity or blood
viscosity caused by a fast rise in plasma triglycerides may
contribute to the circulatory eﬀects of IL infusions
according to the Hagen–Poiseuille law [14]. There are
only few and partially diﬀering results about the eﬀects
of IL infusion on blood viscosity and its determinants
plasma viscosity, red blood cell (RBC) aggregation, and
RBC deformability [15–17].
In preterm and small-for-gestational-age newborns,
intravenous fat elevates the concentrations of triglyce-
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rides and free fatty acids signiﬁcantly more than in
fullterm neonates, children, or adults [18, 19]. These
ﬁndings prompted us to determine blood viscosity and
its determinants (hematocrit, plasma viscosity, and RBC
aggregation and deformabililty) as well as vascular
hindrance in preterm newborns, fullterm neonates, and
children before and after IL infusion.
Patients and methods
Patients and blood samples
Eﬀects of parenterally administered IL were studied in
10 preterm infants (gestational age 26–32 weeks, birth
weight 1,000–2,300 g), 10 fullterm neonates (gestational
age 38–41 weeks, birth weight 2,900–3,600 g), and 10
children (age 0.5–12 years). Excluded were infants and
children with signs of septicemia, arterial hypotension,
pulmonary hypertension, or cardiac or renal disease, as
well as infants and children with serum bilirubin
>12 mg/dl or inspiratory oxygen >40%. None was
being treated with sedatives, analgesics, diuretics, or
vasoactive drugs. In the preterm and fullterm neonates,
IL was started at 48–72 h of postnatal age because they
had not tolerated oral feeding since birth. The children
were given IL because they had not tolerated oral
feeding 48–72 h after an operation. All infants and
children were studied immediately before and after they
received an initial total dose of 6 ml/kg of IL 10% over
4 h. Blood samples were taken before and at the end of
the infusion.
Hemodynamic measurements
Bilateral calf blood ﬂow was measured by venous
occlusion plethysmography using calibrated mercury in
silastic strain gauges. Blood pressure was assessed via
oscillometry (Dinamap Pro Monitor 300, Criticon,
Tampa, USA). In plethysmography and in blood pres-
sure measurements, an average of ﬁve recordings was
used for analysis.
Hematologic methods
Hematocrit was determined by a micro-hematocrit
method. The values were corrected for 2% of trapped
plasma. RBC count, hemoglobin concentration, and
white cell count were determined using a Coulter
Counter (Coulter Electronics, Harpenden, Herts, UK).
Total plasma protein concentration was measured by the
Biuret test. Plasma ﬁbrinogen, immunoglobulin G, and
albumin concentrations were determined via radial-
immunodiﬀusion techniques (M-Partigen kits, Behring,
Marburg, Germany).
Hemorheological methods
All hemorheological measurements were made within
1 h after blood collection. Blood and plasma viscosities
were determined by means of a capillary viscometer [20].
A tube with a diameter of 100 lm and length of 1 cm
was perfused with whole blood and plasma at a tem-
perature of 37 and a pressure of 25 cm H20. Blood and
plasma viscosities (11) were calculated from the passage
times of the samples (ts) and distilled water (tH2O) and
from the viscosity of water at 37 (0.6915 mPas):
g ¼ ts=tH2Oð Þð0:6915Þ:
Relative viscosity was calculated as ratio of blood to
plasma viscosity.
RBC aggregation was assessed at 22C using the
Myrenne Erythrocyte Aggregometer MA2 (Myrenne,
Roetgen, Germany), which consists of a transparent
cone plate viscometer [21]. A blood sample with an ad-
justed hematocrit of 40% is sheared for 20 s to disperse
all RBC aggregates. The drive motor is then stopped,
and the light transmission increases with time at a rate
proportional to the rate of RBC aggregation. The in-
crease in light transmission during 20 s of blood stasis is
measured and displayed as an aggregation index.
The deformability of single RBCs was observed and
measured at 22C using a counter-rotating, cone-plate
rheoscope [22] (Eﬀenberger Munich, Germany), which
was mounted on an inverted microscope (Leitz Diavert,
Wetzlar, Germany). Six shear stresses from 6 to 85 dyn/
cm 2 were applied, and microphotographs of the cells
were taken at each of the shear stresses. Deformation
results in elongation of the RBC, and deformation (D)
is deﬁned as 0=(LW)/(L +W), where L is the length
and W the width of the deformed cell. To achieve shear
stresses causing marked RBC deformation, 5 ll of blood
were diluted 1:50 in a dextran solution with a viscosity of
21 mPas (centipoise).
Statistical evaluation
A paired t-test was used to analyze diﬀerences between
values before and after IL administration within each
group. The magnitude of changes produced by IL in the
diﬀerent groups was compared using an unpaired t-test.
A value of P<0.05 was considered signiﬁcant. Data are
presented as mean ± standard error of the mean (SEM)
unless otherwise speciﬁed.
Ethics
The studies were conducted according to the Helsinki
Declaration and approved by the Ethical Committee of
the Department of Pediatrics of the University of Hei-
delberg. The parents of all infants and children gave
their informed consent.
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Results
Several diﬀerences in hemorheological parameters be-
fore IL infusion were noted among preterm infants,
fullterm neonates, and children: blood viscosity, plasma
viscosity, and RBC aggregation were lower in preterm
infants than in fullterm neonates and reached the highest
values in children (Figs. 1 and 2 and Table 1). As pre-
viously reported, these observations can be related to
diﬀerences in total plasma protein and ﬁbrinogen con-
centrations [20, 21, 23]. The deformability of RBCs
studied by means of a rheoscope did not diﬀer among
the various groups (Fig. 1).
The results of the measured parameters before and
after IL infusion are given in Table 1 and Fig. 1. Basal
serum triglyceride levels were lower in neonates than in
children. After IL infusion, the highest rise in triglycer-
ide levels was observed in preterm infants. Hemoglobin
concentration and hematocrit decreased by about 7%,
blood viscosity fell by about 10%, and RBC aggregation
fell by 20% (Fig. 1). No signiﬁcant changes were noted
in total plasma protein, plasma albumin, immunoglob-
ulin G, ﬁbrinogen, MCV, MCH, MCHC, plasma vis-
cosity, RBC deformation, or blood viscosity at constant
hematocrit of 0.45 (Table 1 and Fig. 1). IL infusion
signiﬁcantly elevated blood pressure in fullterm neonates
and children (from 542±7 to 592±8 mmHg in fullterm
neonates,P<0.05, and from 732±10 to 782±11 mmHg
in children,P<0.05). A slight rise in blood pressure of
preterm infants was not shown to be signiﬁcant (Fig. 2).
Although reduction of peripheral blood ﬂow was not
signiﬁcant in any of the three groups, a signiﬁcant ele-
vation of peripheral resistance (from 4.72±0.6 to
5.22±0.7 mmHg/ml/min 100 ml in preterm in-
fants,P<0.05, from 6.62±0.9 to 7.22±1.2 mmHg/ml/
min 100 ml in fullterm neonates, P<0.05 and from
13.82±1.9 to 15.22±2.4 mmHg/ml/min 100 ml in full-
term neonates,P<0.05) and of vascular hindrance, cal-
culated as the ratio of resistance to blood viscosity (R/
BV) (from 2.22±0.3 to 2.82±0.5 R/BV in preterm in-
fants,P<0.05, from 2.2±0.4 to 2.92±0.6 R/BV in
fullterm neonates,P<0.05 and from 5.42±1.0 to
6.32±0.9 R/BV in children,P<0.05) was found.
Discussion
In agreement with previous studies, we observed that
whole blood viscosity at given hematocrit, plasma
viscosity, and RBC aggregation were lower in preterm
infants than in fullterm neonates and lower in fullterm
neonates than in children and adults. These diﬀerences
have been related to lower plasma proteins in neonates
compared with adults [20, 21, 23, 24]. Plasma viscosity is
strongly dependent on total plasma protein concentra-
tion, but it is more inﬂuenced by macroproteins as
ﬁbrinogen than by smaller proteins as albumin. Aggre-
gation of RBCs is entirely dependent on the concentra-
tion of macroproteins forming bridges among adjacent
RBC [21, 24]. Thus, the steady increase of macroproteins
with gestational and postnatal age explains the con-
comitant rise in RBC aggregation.
We found that IL infusion caused a marked decrease
in RBC aggregation in children and neonates, whereas
Fig. 1 Eﬀects of Intralipid infusion (0.6 g/kg over 4 h) on
hemorheologic parameters
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plasma viscosity and RBC deformation remained un-
changed (Fig. 1). As we reported before, the decrease in
RBC aggregation following in vitro incubation was
strongly dependent on the IL concentration [25]. The in
vitro addition of IL decreased plasma proteins by 1%
(1 mg/ml) to 8% (8 mg/ml). This decline in macropro-
teins could only partially explain the marked decrease of
RBC aggregation. We have previously shown that a
decrease in ﬁbrinogen concentration of 8% reduces RBC
aggregation by 22% in a ﬁbrinogen range of 2–3 g/l [21],
whereas the decrease in RBC aggregation after the
addition of IL at concentrations of 8 mg/ml decreased
RBC aggregation in adults by 50% and abolished RBC
aggregation in the neonates.
Eﬀects of IL infusion on various rheological prop-
erties of blood in adults have recently been reported by
Linde et al. [16]. Thirteen healthy adults received a bolus
injection of 0.5 ml/kg of IL 20% in 10 min followed by
an IL infusion of 90 ml/h over 4 h, resulting in a total IL
dose of approximately 0.4 g/kg.
Using a rotational viscometer, Linde et al. estimated
RBC aggregation from measurements of whole blood
viscosity at a low shear rate of 1/s and RBC deform-
ability from viscosity measurements of RBCs suspended
in buﬀer solution at a hematocrit of 55% and a shear
rate of 1/s [16]. They found a decrease in whole blood
viscosity of 5%, indicating a decrease in RBC aggrega-
tion, and a decrease in the viscosity of RBC buﬀer sus-
pension of about 10% after IL infusion, suggesting an
improvement of RBC deformability. In principle, the
viscosity of RBCs suspended in a protein-free medium at
given hematocrit is determined by RBC deformability
only [22, 26]. However, Linde et al. found no change in
whole blood viscosity at a high shear rate of 1/100 s in
hematocrit and plasma viscosity after IL infusion, al-
though at constant hematocrit and plasma viscosity,
increased RBC deformability should have decreased
whole blood viscosity.
In contrast to the report of Linde et al. [15] and our
results, Rim et al. found a signiﬁcant positive correlation
between whole blood viscosity (measured in a rotational
viscometer at a shear rate of 7.34 S-1) and plasma tri-
glyceride levels in dogs with hyperglyceridemia induced
Table 1 Eﬀects of Intralipid infusion (0.6 g/kg over 4 h) on hematologic parameters
Preterm infants Fullterm neonates Children
Pre Post Pre Post Pre Post
Plasma triglycerides (g/l) 0.13±0.09 2.16±0.22 0.14±0.07 1.64±0.17 0.65±0.1 2.26±0.19
Hemoglobin (g/dl) 15.3±0.5 14.2±0.5 16.4±0.6 14.8±0.4* 12.5±0.3 11.8±0.25
Hematocrit (%) 0.46±0.02 0.43±0.02 50±0.02 0.46±0.02* 0.39±0.01 0.37±.01
MCV (ﬂ) 120±2.8 118±2.5 108±1.9 106±2.2 91±1.3 90±1.3
MCH (pg) 39±1.0 38±1.0 36±0.6 35±1.0 29±0.6 29±1.0
MCHC (g/dl) 33±0.63 33±0.63 33±0.63 32±0.32 32±0.32 32±0.63
Total plasma protein (g/l) 48±1.3 46±1.0 53±1.9 50±0.6 72±2.5 70±2.2
Plasma ﬁbrinogen (g/l) 2.2±0.2 2.1±0.2 2.6±0.2 2.4±0.2 2.8±0.2 2.6±0.2
Values are means ± SEM; *P<O.05 when compared with basal values (paired t-test)
Fig. 2 Eﬀects of Intralipid infusion for 3 h on circulatory param-
eters
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by IL infusion. It is unclear which of the determinants of
blood viscosity (hematocrit, plasma viscosity, RBC de-
formability, or aggregation) was responsible for the tri-
glyceride-dependent rise in blood viscosity, as only
blood viscosity was reported.
The decrease in RBC aggregation after IL infusion
may be explained by an increase in the RBC surface
negativity [27], thereby increasing the repelling forces
between RBCs. Moreover, fatty acids may compete with
the binding sites of macroproteins on the RBC surface
[28]. Our ﬁnding of normalization of RBC aggregation
after resuspending RBCs in IL-free plasma indicates that
IL decreased RBC aggregation as a result of direct ef-
fects of IL compounds on RBCs [25].
Eﬀects of lipids on RBC deformability depend on the
composition of the fatty acids. Docosahexaenoic acid
has been shown to increase RBC deformability [29, 30].
IL contains little docosahexaenoic acid (0.25%) and
therefore does not increase RBC docosahexaenoic acid
[30]. This may explain why IL had no eﬀect on RBC
deformability.
This is, to our knowledge, the ﬁrst investigation to
demonstrate elevated vasoconstriction after IL infusion
in newborns. Vasoconstriction after IL infusion is
known to occur in adults, mainly via an endothelium-
dependent, still unclear mechanism [31]. Above that,
blocking of endothelium-dependent vasorelaxation in
adults has been shown to exclusively occur in the pres-
ence of heparin [31]. Our observations demonstrate that
in newborns and children, mechanisms of vasoconstric-
tion and dilation are diﬀerent from those in adults.
We conclude that an initial infusion of IL at a dose of
0.6 g/kg given in 4 h does not impair ﬂow properties of
blood, but it enhances peripheral vasoconstriction in
neonates and children. RBC aggregation appears to
decrease during IL infusion, suggesting improved blood
ﬂow properties at low shear forces (i.e., in veins). Pre-
viously described pulmonary side eﬀects of IL as
increasing pulmonary arterial pressure thus cannot be
related to impaired ﬂow properties of blood.
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